{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T03:53:33Z","timestamp":1788234813905,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd013198","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000}}],"reference-count":94,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013198.pub2","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T23:46:03Z","timestamp":1610754363000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis"],"prefix":"10.1002","volume":"2021","author":[{"given":"Sadia","family":"Janjua","sequence":"additional","affiliation":[{"name":"Cochrane Airways, Population Health Research Institute; St George's, University of London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G","family":"Mathioudakis","sequence":"additional","affiliation":[{"name":"Division of Infection, Immunity and Respiratory Medicine; The University of Manchester, Manchester Academic Health Science Centre; Manchester UK"},{"name":"North West Lung Centre; Wythenshawe Hospital, Manchester University Foundation Trust; Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Fortescue","sequence":"additional","affiliation":[{"name":"Cochrane Airways, Population Health Research Institute; St George's, University of London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth AE","family":"Walker","sequence":"additional","affiliation":[{"name":"Centre for Reviews and Dissemination; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Sharif","sequence":"additional","affiliation":[{"name":"Centre for Reviews and Dissemination; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher JD","family":"Threapleton","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology; St George's, University of London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Dias","sequence":"additional","affiliation":[{"name":"Centre for Reviews and Dissemination; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"10.1002\/14651858.CD013198.pub2-BIB0001|cit1","first-page":"A6416","article-title":"Chronic azithromycin decreases the frequency of chronic obstructive pulmonary disease exacerbations","volume":"183","author":"Albert","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0002|cit2","first-page":"5","article-title":"Long-term azithromycin decreases COPD exacerbations","volume":"18","author":"Albert","year":"2013","journal-title":"Respirology"},{"issue":"8","key":"10.1002\/14651858.CD013198.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Correction: Azithromycin for prevention of exacerbations of COPD New England Journal of Medicine 2012 366 14","DOI":"10.1056\/NEJMx120012"},{"issue":"12","key":"10.1002\/14651858.CD013198.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/rccm.201402-0207OC","article-title":"Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy","volume":"189","author":"Han","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0006|cit6","first-page":"A4383","article-title":"Chronic azithromycin therapy decreases the risk of re-hospitalization in patients with COPD","volume":"187","author":"Martinez","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00151829-200403010-00007","article-title":"The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomised controlled trial","volume":"3","author":"Banerjee","year":"2004","journal-title":"Treatments in Respiratory Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.rmed.2004.06.009","article-title":"The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD","volume":"99","author":"Banerjee","year":"2005","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1465-9921-14-125","article-title":"Azithromycin and cough-specific health status in patients with chronic obstructive pulmonary disease and chronic cough: a randomised controlled trial","volume":"14","author":"Berkhof","year":"2013","journal-title":"Respiratory Research"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0010|cit10","first-page":"A2449","article-title":"Randomized controlled trial of prophylactic azithromycin on cough-specific health status in patients with chronic obstructive pulmonary disease","volume":"187","author":"Berkhof","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/jpupt.2009.12.002","article-title":"Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy","volume":"23","author":"Blasi","year":"2010","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0012|cit12","first-page":"OA4746","article-title":"Haemophilus dominance of the stable COPD microbiome is associated with greater bacterial load and inflammation and is modulated by prophylactic antibiotic therapy","volume":"46","author":"Brill","year":"2015","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0013|cit13","unstructured":"Brill S Law M Allinson J El-Emir E McHugh T Donaldson G Bacterial resistance induction with prophylactic antibiotics in COPD European Respiratory Journal 2014 P4731"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/thoraxjnl-2015-207194","article-title":"Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial","volume":"70","author":"Brill","year":"2015","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0015|cit15","unstructured":"Brill SE Law M El-Emir E Allinson P Nazareth I Donaldson GC Effect of antibiotics on airway bacteria in patients with chronic obstructive pulmonary disease American Journal of Respiratory and Critical Care Medicine 2014 A2874"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1159\/000321374","article-title":"Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease","volume":"80","author":"Bai","year":"2010","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0017|cit17","unstructured":"Mygind LH Pedersen C Vestbo J Christensen JJ Frimodt-Moller N Kristiansen IS A randomised, placebo-controlled 3 years study of prophylactic azithromycin in 575 patients with chronic obstructive pulmonary disease European Respiratory Society 20th Annual Congress; 2010 Sep 18-22; Barcelona 2010"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0019|cit19","doi-asserted-by":"crossref","unstructured":"Sethi S Jones PW Theron MS Miravitlles M Rubenstein E Wedzicha JA Correction: pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial Respiratory Research 2010 11 88","DOI":"10.1186\/1465-9921-11-88"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-11-10","article-title":"Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomised control trial","volume":"11","author":"Sethi","year":"2010","journal-title":"Respiratory Research"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12952-015-0034-8","article-title":"A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease","volume":"14","author":"Shafuddin","year":"2015","journal-title":"Journal of Negative Results in Biomedicine"},{"issue":"8","key":"10.1002\/14651858.CD013198.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"e105609","DOI":"10.1371\/journal.pone.0105609","article-title":"The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial","volume":"9","author":"Simpson","year":"2014","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pupt.2019\/101831","article-title":"Effect of doxycycline in chronic obstructive pulmonary disease - an exploratory study","volume":"101831","author":"Singh","year":"2019","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1378\/chest.120.3.730","article-title":"Erythromycin and common cold in COPD","volume":"120","author":"Suzuki","year":"2001","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0025|cit25","doi-asserted-by":"crossref","unstructured":"Tan C Huang H Zhang J He Z Zhong X Bai J Effects of low-dose and long-term treatment with erythromycin on IL-17 and IL-23 in peripheral blood and induced sputum in patients with stable chronic obstructive pulmonary disease Chest 2016 387A","DOI":"10.1016\/j.chest.2016.02.402"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4173962","article-title":"Effects of low-dose and long-term treatment with erythromycin on interleukin-17 and interleukin-23 in peripheral blood and induced sputum in patients with stable chronic obstructive pulmonary disease","volume":"4173962","author":"Bai","year":"2016","journal-title":"Mediators of Inflammation"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0027|cit27","doi-asserted-by":"crossref","unstructured":"Djamin RS Uzun S Ermens AAM Kerstens R Hoogsteden HC Aerts JGJV Which predictors in COPD patients with the frequent exacerbator phenotype predict the treatment response to maintenance therapy with azithromycin? European Respiratory Journal 2016 PA3713","DOI":"10.1183\/13993003.congress-2016.PA3713"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0028|cit28","unstructured":"Uzun S Djamin RS Aerts JGJV Van Der Eerden MM Patients with COPD Gold C & D: the effect of long-term treatment with azithromycin on exacerbation risk assessed by the Gold Framework American Journal of Respiratory and Critical Care Medicine 2014 A5967"},{"issue":"5","key":"10.1002\/14651858.CD013198.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-2600(14)70019-0","article-title":"Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind,placebo-controlled trial","volume":"2","author":"Uzun","year":"2014","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0030|cit30","doi-asserted-by":"crossref","unstructured":"Uzun S Djamin RS Mulder PGH Kluytmans JAJW Pelle AJ Van't Veer NE Effect of azithromycin maintenance treatment in patients with frequent exacerbations of COPD (COLUMBUS): a randomised, double-blind, placebo-controlled trial American Journal of Respiratory and Critical Care Medicine 2014 A2884","DOI":"10.1016\/S2213-2600(14)70019-0"},{"issue":"7","key":"10.1002\/14651858.CD013198.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1164\/rccm.201901-0094OC","article-title":"Azithromycin during acute chronic obstructive pulmonary disease exacerbations requiring hospitalisation (BACE). A multi-centre, randomised, double-blind, placebo-controlled trial","volume":"200","author":"Vermeersch","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013198.pub2-BIB0032|cit32","first-page":"260","article-title":"Effect of azithromycin in combination with simvastatin in the treatment of chronic obstructive pulmonary disease complicated by pulmonary arterial hypertension","volume":"33","author":"Wang","year":"2017","journal-title":"Pakistan Journal of Medicine Science"},{"issue":"5","key":"10.1002\/14651858.CD013198.pub2-BIB0033|cit33","first-page":"351","article-title":"Assessment of chemoprophylaxis with intermittent tetracycline in chronic bronchitis. A functional follow-up for 3 years","volume":"8","author":"Bussi","year":"1980","journal-title":"Revue Francaise des Malades Respiratoires"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0007-0971(68)80040-3","article-title":"A five year study of bacteriology and prophylactic chemotherapy in patients with chronic bronchitis","volume":"62","author":"Calder","year":"1968","journal-title":"British Journal of Diseases of the Chest"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0007-0971(61)80020-X","article-title":"Chronic bronchitis: changes in the bacterial flora of the sputum associated with exacerbations and long-term antibacterial treatment","volume":"55","author":"Cooper","year":"1961","journal-title":"British Journal of Diseases of the Chest"},{"issue":"5102","key":"10.1002\/14651858.CD013198.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/bmj.2.5103.1010","article-title":"Adult chronic bronchitis - continuous antibiotic therapy","volume":"2","author":"Edwards","year":"1958","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0037|cit37","unstructured":"Phase II, randomised, double arm, multi-centre study evaluating the efficacy and safety of azithromycin for the long term prophylactic treatment of COPD in primary antibody deficiency patients with clinical spirometrically confirmed COPD suffering from repeated acute exacerbations www.clinicaltrialsregister.eu\/ctr-search\/search?query=2011-004351-39"},{"issue":"5169","key":"10.1002\/14651858.CD013198.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bmj.1.5169.297","article-title":"Influence of daily penicillin and tetracycline on exacerbations and their cost","volume":"30","author":"Francis","year":"1960","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0039|cit39","unstructured":"The effectiveness of antibiotics compared to no antibiotics for exacerbations of chronic obstructive pulmonary disease: a feasibility study www.isrctn.com\/ISRCTN72035428"},{"issue":"43","key":"10.1002\/14651858.CD013198.pub2-BIB0040|cit40","first-page":"1","article-title":"The opportunity and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials","volume":"18","author":"Staa","year":"2014","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0041|cit41","first-page":"197","article-title":"Antibiotic prophylaxis in primary antibody deficiency patients: study design","volume":"37","author":"Milito","year":"2017","journal-title":"Journal of Clinical Immunology"},{"issue":"Suppl 63","key":"10.1002\/14651858.CD013198.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"RCT5100","DOI":"10.1183\/13993003.congress-2019.RCT5100","article-title":"Low dose azithromycin prophylaxis in primary antibody deficiencies","volume":"54","author":"Milito","year":"2019","journal-title":"European Respiratory Journal"},{"issue":"5162","key":"10.1002\/14651858.CD013198.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bmj.2.5162.1277","article-title":"Evaluation of continuous antibiotic therapy in chronic bronchitis","volume":"2","author":"Murdoch","year":"1959","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD013198.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11845-015-1372-8","article-title":"Assessing potential risks of treatment with long-term azithromycin in COPD patients: long-term oxygen users beware?","volume":"185","author":"Nicholson","year":"2016","journal-title":"Irish Journal of Medical Science"},{"issue":"12","key":"10.1002\/14651858.CD013198.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2013-004140","article-title":"Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations","volume":"3","author":"O'Reilly","year":"2013","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0046|cit46","first-page":"A1021","article-title":"Long term effects of antibiotics in COPD exacerbations: a randomised clinical trial","volume":"193","author":"Van Velzen","year":"2016","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"10","key":"10.1002\/14651858.CD013198.pub2-BIB0047|cit47","first-page":"1194","article-title":"A well-controlled comparative clinical study of the combination regimen of ciprofloxacin plus erythromycin for the treatment of repeated acute exacerbations of chronic respiratory tract infections","volume":"42","author":"Watanabe","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0048|cit48","unstructured":"Zykov K Rvatcheva A Pustovalov A Averyanov A Long term treatment with clarithromycin of stage II COPD patients with frequent exacerbations European Respiratory Society 18th Annual Congress; 2008 Oct 3-7; Berlin 2008"},{"issue":"4","key":"10.1002\/14651858.CD013198.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/thoraxjnl-2012-202698","article-title":"Azithromycin for prevention of exacerbations in severe asthma (AZIAST): a multi-centre randomised double-blind placebo-controlled trial","volume":"68","author":"Brusselle","year":"2013","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.2147\/COPD.S181246","article-title":"Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis","volume":"13","author":"Cui","year":"2018","journal-title":"International Journal of COPD"},{"issue":"5","key":"10.1002\/14651858.CD013198.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modelling framework for pairwise and network meta-analysis of randomised controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Medical Decision Making"},{"issue":"5","key":"10.1002\/14651858.CD013198.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0272989X12455847","article-title":"Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomised controlled trials","volume":"33","author":"Dias","year":"2013","journal-title":"Medical Decision Making"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/9781118951651.ch9","volume-title":"Network Meta-Analysis for Decision-Making","author":"Dias","year":"2018"},{"issue":"10","key":"10.1002\/14651858.CD013198.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.rmed.2013.05.004","article-title":"A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with chronic obstructive pulmonary disease","volume":"107","author":"Donath","year":"2013","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jrsm.1049","article-title":"Accounting for correlation in mixed treatment comparisons with multi-arm trials","volume":"3","author":"Franchini","year":"2012","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0057|cit57","unstructured":"Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2020 Report www.guidelines.co.uk\/respiratory\/gold-copd-2020-strategy\/455088.article"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jclinepi.2017.05.005","article-title":"GRADE Guidelines 17: Assessing the risk of bias associated with missing participant outcome data in a body of evidence","volume":"87","author":"Guyatt","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1002\/14651858.CD013198.pub2-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009764.pub3","article-title":"Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)","author":"Herath","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0060|cit60","doi-asserted-by":"crossref","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"issue":"5","key":"10.1002\/14651858.CD013198.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4187\/respcare.05943","article-title":"Prophylactic antibiotic use in COPD and the potential anti-inflammatory activities of antibiotics","volume":"63","author":"Huckle","year":"2018","journal-title":"Respiratory Care"},{"issue":"12","key":"10.1002\/14651858.CD013198.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0063|cit63","unstructured":"Supplementary material: Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis. [data set] Zenodo 2021 10.5281\/zenodo.4428848"},{"issue":"3","key":"10.1002\/14651858.CD013198.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010844.pub2","article-title":"Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis","author":"Kew","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD013198.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5588\/ijtld.12.0401","article-title":"Systematic review and meta-analysis of prophylactic antibiotics in COPD and\/or chronic bronchitis","volume":"17","author":"Lee","year":"2013","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"2","key":"10.1002\/14651858.CD013198.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/1389450111314020008","article-title":"Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation","volume":"14","author":"Loukides","year":"2013","journal-title":"Current Drug Targets"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/sim.3680","article-title":"The BUGS project: evolution, critique and future directions (with discussion)","volume":"28","author":"Lunn","year":"2009","journal-title":"Statistics In Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013198.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/COPD.S681","article-title":"Role of macrolide therapy in chronic obstructive pulmonary disease","volume":"3","author":"Martinez","year":"2008","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"143","key":"10.1002\/14651858.CD013198.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"160073","DOI":"10.1183\/16000617.0073-2016","article-title":"Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis","volume":"26","author":"Mathioudakis","year":"2017","journal-title":"European Respiratory Review"},{"issue":"6","key":"10.1002\/14651858.CD013198.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/thoraxjnl-2019-214484","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits","volume":"75","author":"Mathioudakis","year":"2020","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pupt.2014.05.002","article-title":"Antibiotic prophylaxis in COPD: why, when, and for whom?","volume":"32","author":"Miravittles","year":"2015","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD013198.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0073|cit73","unstructured":"Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00524095 2009"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0074|cit74","unstructured":"A study to evaluate the anti-inflammatory effects of solithromycin in chronic obstructive pulmonary disease https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02628769 2017"},{"issue":"3","key":"10.1002\/14651858.CD013198.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"e0121257","DOI":"10.1371\/journal.pone.0121257","article-title":"Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis","volume":"10","author":"Ni","year":"2015","journal-title":"PLoS One"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0076|cit76","unstructured":"National Institute of Health and Clinical Excellence Chronic obstructive pulmonary disease in over 16s: diagnosis and management (NG115) www.nice.org.uk\/guidance\/ng115"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0077|cit77","unstructured":"National Institute for Health and Care Excellence Chronic obstructive pulmonary disease in 16s: diagnosis and management NG115. Recommendations www.nice.org.uk\/guidance\/ng115\/chapter\/Recommendations"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/COPD.S36997","article-title":"Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population","volume":"7","author":"Pasquale","year":"2012","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"3","key":"10.1002\/14651858.CD013198.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/rssa.12341","article-title":"Sensitivity of treatment recommendations to bias in network meta-analysis","volume":"181","author":"Phillippo","year":"2018","journal-title":"Journal of the Royal Statistical Society"},{"issue":"8","key":"10.1002\/14651858.CD013198.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7326\/M18-3542","article-title":"Threshold analysis as an alternative to GRADE for assessing confidence in guideline recommendations based on network meta-analyses threshold analysis in guideline development","volume":"170","author":"Phillippo","year":"2019","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013198.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1477-7525-4-94","article-title":"Combining scores from different patient reported outcome measures in meta-analyses: when is it justified?","volume":"7","author":"Puhan","year":"2006","journal-title":"Health and Quality of LIfe Outcomes"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jclinepi.2014.08.012","article-title":"Predictive distributions were developed for the extent of heterogeneity in meta-analysis of continuous outcome data","volume":"68","author":"Rhodes","year":"2015","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD013198.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/49.4.593","article-title":"Cardiotoxicity of fluoroquinolones","volume":"49","author":"Rubinstein","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD013198.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/thx.2005.041822","article-title":"COPD exacerbations. 2: Aetiology","volume":"61","author":"Sapey","year":"2006","journal-title":"Thorax"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD013198.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Americal Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013198.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1513\/pats.2306029","article-title":"Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?","volume":"1","author":"Sethi","year":"2004","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0087|cit87","first-page":"179","article-title":"Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial","volume":"9","author":"Siva","year":"2014","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0088|cit88","first-page":"1","article-title":"British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease","volume":"0","author":"Smith","year":"2020","journal-title":"British Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD013198.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0090|cit90","first-page":"229","article-title":"Bacterial microbiome of lungs in COPD","volume":"9","author":"Sze","year":"2014","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"6","key":"10.1002\/14651858.CD013198.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/sim.6381","article-title":"Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis","volume":"34","author":"Turner","year":"2015","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1093\/jac\/dky326","article-title":"Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomised controlled trials","volume":"73","author":"Wang","year":"2018","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD013198.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000350828","article-title":"Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis","volume":"86","year":"2013","journal-title":"Respiration"},{"issue":"5","key":"10.1002\/14651858.CD013198.pub2-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013024","article-title":"Head-to-head oral prophylactic antibiotics therapy for chronic obstructive pulmonary disease","author":"Threapleton","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T20:47:55Z","timestamp":1630356475000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013198.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013198.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]}}}